Oncogenic Braf induces melanocyte senescence and melanoma in mice

Nathalie Dhomen1, Jorge S Reis-Filho, Silvy da Rocha Dias

  • 1Signal Transduction Team, Cancer Research UK Centre for Cell and Molecular Biology, The Institute of Cancer Research, London, UK.

Cancer Cell
|April 7, 2009
PubMed

Insights

Inducible Braf(V600E) expression in mice causes skin hyperpigmentation and melanoma. This new mouse model accurately reflects human melanoma genetics and pathology, aiding further research.

Area of Science:

  • Oncology
  • Dermatology
  • Genetics

Background:

  • The BRAF V600E mutation is a key driver in melanoma development.
  • Existing mouse models often do not fully recapitulate human melanoma's complexity.

Purpose of the Study:

  • To develop a novel mouse model for studying melanoma driven by Braf(V600E) at physiological levels.
  • To investigate the role of Braf(V600E) in melanoma initiation, progression, and senescence.

Main Methods:

  • Inducible expression of Braf(V600E) in endogenous Braf gene in mouse melanocytes.
  • Histological and molecular analysis of skin lesions and tumors.
  • Assessment of tumor cell colonization in nude mice.

Main Results:

  • Braf(V600E) expression induced skin hyperpigmentation, nevi with senescent melanocytes, and melanoma in approximately 70% of mice.
  • The developed melanomas mirrored key features of human melanoma.
  • Tumor suppressor p16(INK4a) was not essential for senescence induction or tumor progression but influenced latency and penetrance.

Conclusions:

  • A Braf(V600E)-driven mouse model accurately reflects human melanoma pathology and genetics.
  • This model provides a valuable tool for understanding melanoma development and testing therapeutic strategies.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...